V017-0143 Screening compound: N-[1-(2-cyclopentylacetyl)-4-piperidyl]-3-[(4-fluorobenzoyl)amino]-2-pyrazinecarboxamide

V017-0143 Screening compound: N-[1-(2-cyclopentylacetyl)-4-piperidyl]-3-[(4-fluorobenzoyl)amino]-2-pyrazinecarboxamide
V017-0143 Screening compound: N-[1-(2-cyclopentylacetyl)-4-piperidyl]-3-[(4-fluorobenzoyl)amino]-2-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-0143
N-[1-(2-cyclopentylacetyl)-4-piperidyl]-3-[(4-fluorobenzoyl)amino]-2-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-0143

Molecular Formula

C24H28FN5O3 (C24 H28 FN5 O3)

Compound Name

N-[1-(2-cyclopentylacetyl)-4-piperidyl]-3-[(4-fluorobenzoyl)amino]-2-pyrazinecarboxamide

IUPAC name

N-[1-(2-cyclopentylacetyl)piperidin-4-yl]-3-(4-fluorobenzamido)pyrazine-2-carboxamide

SMILES

O=C(CC1CCCC1)N(CC1)CCC1NC(c1nccnc1NC(c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C24H28FN5O3/c25-18-7-5-17(6-8-18)23(32)29-22-21(26-11-12-27-22)24(33)28-19-9-13-30(14-10-19)20(31)15-16-3-1-2-4-16/h5-8,11-12,16,19H,1-4,9-10,13-15H2,(H,28,33)(H,27,29,32)

InChI Key

FSFLIYRGRNFLNV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19927424

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

453.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.219

Distribution Coefficient, logD

0.390

Water Solubility, LogSw

-2.74

Polar Surface Area

83.461

Acid Dissociation Constant (pKa)

5.58

Base Dissociation Constant (pKb)

-0.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.83

V017-0143 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Anti-HIV1 Library (19540 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with V017-0143 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-0143?
Check Price and Availability of V017-0143, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-0143 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-0143
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-0143
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-0143 available by request